Search results for: 'development ba09 iot'

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

02 Mar 2020  |  Global  |  Market Research

Convergence of AI and IoT—Market Opportunities and Challenges, 2019

Transformative Impact of Artificial Intelligence and Internet of Things will Enable New Levels of Prediction and Automation in IIoT Environments

Infographics

×

The convergence of Internet of Things (IoT) and artificial intelligence (AI) has the potential to drive new revenues for vendors and adopters. Improved efficiency and cost optimization of organizational processes are core advantages that are made possible through the application of such solutions. IoT-AI convergence can deliver new advantages in t...

This Frost & Sullivan research examines the growing need for artificial intelligence (AI) services to help businesses meet key goals and objectives, as well as the strategic position of public cloud service providers to develop and launch successful AI capabilities for customers. The report discusses the importance of public cloud providers in the ...

This research service provides a strategic analysis of the implications of shale gas development in South Africa. The research service explores the market drivers, restraints, and challenges from a cost benefit perspective pertaining to both the environment and the economy. Key focus is based on implications of shale gas in South Africa's power gen...

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

The study analyses the Kenyan and Rwandan health care landscape, market outlook, and investment and growth opportunities. It also discusses the drivers and restraints and the dynamics of the hospital construction market and concludes by providing a list of upcoming projects and strategic recommendations for the markets in Kenya and Rwanda. The res...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

Connected devices are set to increase exponentially over the next 7 years, and global industry revenues from 5G and Internet of Things (IoT) are expected to reach USD 619 billion by 2026. Networks will need to be able to accommodate the billions of additional IoT mobile devices that will be connected across the globe as well as cater to the mobile ...